CDMOs offering Microbial Fermentation with Small Molecule
8 published
8 published CDMOs match Microbial Fermentation and Small Molecule.
Locations in this set include United Kingdom, United States, India, Canada, China, and France.
Capabilities that show up most often in this set: CMC Analytical Development, Process Development, API Synthesis & Manufacturing, Downstream Processing, and Small Molecule Development & Manufacturing.
Matching companies
- Asymchem LaboratoriesAsymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry.
BOC SciencesBOC Sciences is a custom lab chemical supplier offering bulk compounds, custom synthesis, cGMP manufacturing, analytical services, and specialized drug delivery and bioconjugation platforms for pharmaceutical and biotechnology clients.
BioVectraNorth American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.
Charles River LaboratoriesCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
CuriaGlobal CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.
IsomeraseIsomerase is a synthetic biology company offering fee-for-service lab work, consultancy, and bioproduction, process development and scale-up for pharma, agritech and chemical clients. Its platform covers enzyme engineering, microbial hosts and cell-free protein synthesis.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /explore/microbial-fermentation/small-molecule.md